0
Original Article | ONLINE FIRST

Fate of the Pancreatic Remnant After Resection for an Intraductal Papillary Mucinous Neoplasm:  A Longitudinal Level II Cohort Study

Toshiyuki Moriya, MD, PhD; L. William Traverso, MD
Arch Surg. 2012;147(6):528-534. doi:10.1001/archsurg.2011.2276.
Text Size: A A A
Published online

Objective  To determine the occurrence of new disease in the pancreatic remnant after resection for intraductal papillary mucinous neoplasms.

Design  A longitudinal level II cohort study.

Setting  Virginia Mason Medical Center, Seattle, Washington.

Patients  The primary cohort was a “resection cohort” of 203 patients who underwent partial pancreatic resection for an intraductal papillary mucinous neoplasm.

Main Outcome Measures  The occurrence rate of lesions in the pancreatic remnant after resection for an intraductal papillary mucinous neoplasm, determined by use of an annual computed tomographic scan of the pancreas.

Results  New lesions were observed in the remnant of 17 of the 203 patients (8%) after a median follow-up of 40 months and a median interval of 38 months from the initial resection. Only 1 of these 17 patients with new lesions had a surgical margin that was positive for an adenoma at the time of resection. Comparing the 17 patients with new lesions with the 186 patients without new lesions, we found no difference in age, sex, procedure type, location in ductal system, original histology, or original margin status. In the new lesion group, no treatment was used for 12 patients who had side-branch disease detected by imaging (6% of all patients). Surgical treatment was used for 5 patients (2% of all patients): 2 with adenomas, 1 with a carcinoma in situ, and 2 with an invasive ductal carcinoma (1 with liver metastases).

Conclusions  We found that, following a partial pancreatic resection for an intraductal papillary mucinous neoplasm and a 40-month follow-up with an annual computed tomographic scan of the pancreas, 17 of 203 patients (8%) developed a new intraductal papillary mucinous neoplastic lesion in the pancreatic remnant. As follow-up time increases, we suspect that new lesions will constantly appear regardless of whether the surgical margin was negative at initial resection.

Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Place holder to copy figure label and caption
Grahic Jump Location

Figure 1. Flowchart of 219 patients in our longitudinal level II cohort study. During the original pancreatic resection, 14 of 203 patients (7%) had residual lesions in their pancreatic remnants that did not meet criteria for resection by international criteria. These lesions were intentionally left in the remnant to preserve pancreatic parenchyma. The remaining 189 patients (93%) had no residual lesions in their pancreatic remnants after their first resections. After a median follow-up period of 40 months (range, 3-127 months), new lesions developed in the pancreatic remnants of 17 patients (8%). Therefore, 31 of 203 patients (15%) had lesions in their pancreatic remnants at the end of the follow-up period. IPMN indicates intraductal papillary mucinous neoplasm.

Place holder to copy figure label and caption
Grahic Jump Location

Figure 2. Flowchart of 31 of 203 patients (15%) with lesions found in the pancreatic remnants who underwent a partial pancreatic resection. Fourteen of the 31 patients had residual lesions intentionally left in their remnants during their first pancreatic resections. All 14 patients had residual lesions that were considered side-branch duct (SBD)–type intraductal papillary mucinous neoplasms that were less than 3 cm in diameter. None of these residual lesions changed in size during the median follow-up period of 40 months. New lesions were observed in the pancreatic remnants of 17 patients (8%). Of these 17 patients, 15 had cystic lesions, and 2 had solid lesions. Two of these patients had lesions that were located in the main pancreatic duct (MPD), 1 patient had lesions that were located in the MPD and SBD (mixed lesions), and 12 patients had lesions that were located in the SBD. We observed all 12 patients with SBD lesions for a median of 50 months (range, 13-112 months), and all of these lesions remained the same size. Secondary operations were felt necessary in 5 cases (with 4 cases having lesions that were resected); the criteria were MPD location (3 patients) and suspicious solid lesion (2 patients). The pathological findings for the MPD lesions were carcinoma in situ (CIS; 1 patient) and adenoma (2 patients), and both solid lesions were invasive adenocarcinomas arising in the MPD.

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

October 1, 2012
Adam E. Frampton, MSc, MRCS; Madhava Pai, MS, FRCS; Jonathan Krell, BSc, MRCP; Panagiotis Vlavianos, MD; Long R. Jiao, MD, FRCS; Duncan R. C. Spalding, MD, FRCS
Arch Surg. 2012;147(10):977-980. doi:10.1001/archsurg.2012.2287.
CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 2

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
Jobs